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It is generally accepted that most colorectal carcinomas arise in pre-existing adenomas. Morphologically, colorectal adenomas can be
divided into two groups, protruded type and flat type. The aim of this study was to clarify relevant alterations of gene expression
associated with the early stage of colorectal carcinogenesis. Using cDNA array, we analysed the expression profiles of 550 cancer-
related genes in 36 colorectal adenomas (18 flat-type and 18 protruded-type adenomas) and 14 early invasive carcinomas. Among
the 550 genes, we chose 32 genes the average expression levels of which were at least three-fold up- or downregulated in tumour
tissues compared with levels in matched normal tissues. A total of 13 and 19 genes were identified as up- and downregulated genes
in tumour tissues, respectively. Among the upregulated genes, the average expression levels of E1AF, bone morphogenic protein
(BMP)-4, insulin-like growth factor (IGF)-2, inducible nitric oxide synthase (iNOS), tissue inhibitors of metalloproteinase (TIMP)-1,
Smad4, and nm23 in tumour tissues were over five times higher than those in matched normal tissues. Colorectal adenomas and
early invasive carcinomas were divided into two major clusters by clustering analysis. Moreover, flat- and protruded-type adenomas
were divided into two major clusters by clustering analysis. The expression profiles obtained by the cDNA array clearly indicate that
colorectal adenomas and early invasive carcinomas have specific expression profiles. Likewise, the gene expression profiles of flat- and
protruded-type adenomas are different. These results indicate that molecular classification of early colorectal tumours by a cDNA
array is feasible.
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Colorectal carcinoma is one of the most common human
malignancies in the world. Although alternative pathways exist,
it is generally accepted that most colorectal carcinomas arise in
pre-existing adenomas (Jass et al, 2002). Despite a large number of
studies, little is known about molecular alterations associated with
the heterogeneity of colorectal carcinomas.
Morphologically, early colorectal tumors can be divided into two
groups, protruded type and flat type. Recently, flat-type colorectal
tumours have been reported not only in Japan (Sakashita et al,
2000) but also in Western countries (Olschwang et al, 1998).
Previous studies showed that flat-type colorectal tumours tended
to reach deeper layers earlier and to show higher rates of lymphatic
invasion and lymph node metastasis than did protruded-type
tumours (Kuramoto and Oohara, 1989; Mueller et al, 1998).
Moreover, it has been thought that some flat-type cancers
correspond to de novo cancers, which contain no observable
adenomatous component and may develop through a distinct
genetic pathway (Yashiro et al, 2001). Thus, it would be interesting
to examine gene expression profiles of colorectal adenomas and
early invasive colorectal carcinomas, because comparison of these
two groups of tumours will provide information about genes that
play an important role during progression from adenoma to
carcinoma.
DNA array technology enables measure of the mRNA expression
levels of thousands of genes in a single assay. Mainly advanced
cancer has been analysed in gene expression profiling-based
studies on colorectal cancer (Alon et al, 1999; Backert et al, 1999;
Hegde et al, 2001; Kitahara et al, 2001; Notterman et al, 2001;
Takemasa et al, 2001; Agrawal et al, 2002; Birkenkamp-Demtroder
et al, 2002; Lin et al, 2002; Zou et al, 2002; Frederiksen et al, 2003;
Muro et al, 2003; Tureci et al, 2003; Williams et al, 2003; Bertucci
et al, 2004). Only a small number of adenoma and early invasive
cancer tissues have been analysed in previous studies, and the
issue of flat- and protruded-type adenoma tissues has not been
directly addressed (Notterman et al, 2001; Agrawal et al, 2002; Lin
et al, 2002; Williams et al, 2003).
In this study, we therefore applied cDNA array technology to
analyse the gene expression profiles of 36 colorectal adenomas (18
flat-type and 18 protruded-type adenomas) and 14 early invasive
carcinomas. This is the first study showing molecular classification
of early colorectal tumours by a cDNA array analysis.
MATERIALS AND METHODS
Patients and tissue samples
A total of 50 paired specimens of colorectal tumour and
nontumour tissues were obtained by polypectomy or surgical
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streatment. These tumour samples consisted of 36 colorectal
adenomas and 14 early invasive carcinomas (pT1 in the TNM
classification of the Union International Contre Cancer). Normal
epithelial tissue samples and tumour tissue samples were carefully
macrodissected by expert pathologists. In case of early invasive
carcinomas, tumour tissue samples were taken from the macro-
scopically visible deepest invading part of the tumour after surgical
resection. Each tissue specimen was divided into two pieces after
resection. For total RNA extraction, one sample was immediately
frozen in liquid nitrogen at the time of surgery and stored at
 801C until extraction. The other sample was processed for
pathological examination using haematoxylin and eosin staining
for the evaluation of the tumour cell content. Only specimens
containing more than 80% tumour cells were used for analysis
(Horiuchi et al, 2003). The histopathological features of the
carcinoma specimens were classified according to the TNM
classification system. Locations of the colorectal tumours were
divided into proximal colon (caecum and ascending and transverse
colon) and distal colon (descending and sigmoid colon and
rectum). Macroscopic types were divided into protruded type
(height of tumour X3mm) and flat type (height of tumour
o3mm). It was difficult to divide early invasive carcinoma into
protruded type or flat type because colorectal tumours become
thick when they have invaded the submucosal layer. Therefore,
macroscopic type was classified in only colorectal adenomas. The
clinicopathological characteristics of colorectal tumours are shown
in Table 1. Informed consent was obtained from each subject, and
the institutional review committee approved this study.
cDNA array analysis
Total RNA was extracted from specimens using the acid
guanidinum thiocyanate–phenol–chloroform extraction method
and treated with DNase I. Biotin-labelled cDNA targets were made
from 2.5mg of total RNA using Gene Navigator cDNA amplifica-
tion system (Toyobo, Osaka, Japan), including random 9-mer,
biotin-16-dUTP, and ReverTraAceTM reverse transcriptase. Free
biotin-16-dUTP in the reaction was removed by ethanol precipita-
tion. Gene Navigator cDNA array filter (human cancer, Toyobo)
consisted of 550 cancer-related genes and 11 housekeeping genes
in duplicate. A complete list is available on the Internet (http://
www.toyobo.co.jp). Hybridisation was performed overnight at
681C in PerfectHybTM (Toyobo). Filters were washed three times
in 2 SSC/0.1% SDS at 681C for 10min each, followed by three
washes in 0.1 SSC/0.1% SDS at 681C for 10min each. Specific
signals on the filters were detected by the chemiluminescence
detection kit (Imaging highTM, Toyobo). CDP-Star was used as the
chemiluminescent substrate. Quantitative assessment of the signals
on the filters was performed by scanning on a Fluor-S MultiImager
System (Bio-Rad, Richmond, CA, USA) followed by image analysis
using ImaGene software (BioDiscovery, Los Angeles, CA, USA).
The data were analysed with normalisation to glyceraldehyde-3-
phosphate dehydrogenase (GAPDH) expression. The average of
three experiments was calculated.
Statistical analysis
Expression of each target gene was assessed for associations with
clinicopathological characteristics using Mann–Whitney U-test for
average tumour expressions.
RESULTS
cDNA array analysis
To clarify relevant alterations of gene expression associated with
early colorectal carcinogenesis, we analysed the gene expression
profiles of tumour tissues by a cDNA array (Yamamoto et al,
2002). Gene Navigator cDNA array filter (human cancer, Toyobo)
consisted of 550 cancer-related genes and 11 housekeeping genes
in duplicate. Among the 550 genes the expression profiles of which
were analysed, we chose 32 genes the average expression levels of
which were at least three-fold up- or downregulated in 50 tumour
tissues compared with levels in 50 matched normal tissues.
Besides, since many colorectal tumours have been demonstrated
to have a diversity of gene expression profiles, we examined the
ratios of the selected 32 genes in all 50 tumour/normal pairs
individually. The selected genes were classified as commonly
changed if their ratio was three-fold up- or downregulated in more
than one-third (15 of 50) of the patients. Among the selected 32
genes, all genes satisfied these criteria. A total of 13 genes (insulin-
like growth factor (IGF)-2 bone morphogenic protein (BMP)-4,
ECGF-1, E1AF, FAK, Rho GDIb, nm23, tissue inhibitors of
metalloproteinase (TIMP)-1, GSTP1, GST-II, Smad4, inducible nitric
oxide synthase (iNOS), and c-jun) and 19 genes (Egr-2, PMS1, Eph,
gp130, Rho 8, Ras-GAP, p120, GAK, Erk1, Lamin b3, Cdc42,
aN-catenin, MMP-15, Galectin-1, HLA-DQ, MUC-2, MDR1, Mucin3,
and p21) were identified as up- and downregulated genes in tumour
tissues, respectively. These genes were associated with transcription
(Egr-2 and E1AF), DNA repair or protection (PMS1, GSTP1,
and GST-II), cell signalling (Eph, gp130, Rho 8, Ras-GAP, p120,
GAK, Rho GDIb, Erk1, FAK, and Lamin b3), cell cycle (Cdc42),
growth factor (IGF-2, BMP-4, and ECGF-1), tumour suppressor
(nm23 and Smad4), oncogene (c-jun), cell adhesion (aN-catenin),
extracellular matrix-degrading enzymes (MMP-15, TIMP-1,
and Galectin-1), human leucocyte antigen (HLA-DQ), glycopro-
tein (MUC-2, MDR1, and Mucin3), CDK inhibitor (p21), and
angiogenesis (iNOS).
Among the 13 genes the average expression levels of which were
at least three-fold upregulated in tumour tissues compared with
levels in matched normal tissues, the average expression levels of
E1AF, BMP-4, IGF-2, iNOS, TIMP-1, Smad4, and nm23 genes in
tumour tissues were over five times higher than those in matched
normal tissues (Table 2). Semiquantitative reverse transcriptase–
polymerase chain reaction (RT–PCR) analysis of these differen-
tially expressed genes gave results consistent with those by a cDNA
array analysis (Figure 1).
Colorectal adenomas (n¼36) and early invasive carcinomas
(n¼14) were divided into two major clusters by clustering analysis
(Figure 2). The average expression levels of 10 (IGF-2, E1AF, iNOS,
Rho GDIb, GSTP1, c-jun, ECGF1, nm23, Smad4, and TIMP-1) of
the 32 genes were significantly higher in the early invasive
carcinoma group than in the adenoma group. On the other hand,
the average expression levels of 12 (Eph, gp130, GST-II, Rho 8,
MUC-2, Ras-GAP, p120, MDR1, aN-catenin, Egr-2, PMS1, and
Table 1 Clinicopathological characteristics of patients with colorectal
tumour
Adenoma (n¼36)
Characteristics
Early invasive
carcinoma
(n¼14)
Protruded type
(n¼18)
Flat type
(n¼18)
Age (years, mean7s.d.) 69.177.3 67.975.8 71.174.9
Size (mm, mean7s.d.) 25.7710.0 10.575.4 14.2712.7
Gender
Male 8 11 13
Female 6 7 5
Location
Proximal 9 5 10
Distal 5 13 8
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sGAK) of the 32 genes were significantly lower in the early invasive
carcinoma group than in the adenoma group (Table 3).
Flat-type (n¼18) and protruded-type (n¼18) adenomas were
divided into two major clusters by clustering analysis (Figure 3).
The average expression levels of 16 (PMS1, nm23, p21, FAK,
Smad4, c-jun, ECGF-1, Erk1, GAK, GSTP1, IGF-2, Laminin b-3,
MMP-15, Mucin3, Rho GDIb, and TIMP-1) of the 32 genes were
significantly higher in the flat-type group than in the protruded-
type group, while the average expression levels of 11 (HLA-DQ,
Cdc42, Egr-2, Eph, Galectin-1, gp130, GST-II, MDR1, p120, Ras-
GAP, and Rho 8) of the 32 genes were significantly lower in the
flat-type group than in the protruded-type group (Table 4).
Among the 32 genes, the average expression levels of eight genes
(Rho GDIb, c-jun, iNOS, TIMP-1, GSTP1, ECGF1, nm23, and
Smad4) and four genes (MUC-2, aN-catenin, PMS1, and GAK)
were significantly lower and higher, respectively, in both the flat-
and protruded-type adenoma groups than in the early invasive
carcinoma group. The average expression levels of two genes
(Cdc42 and Galectin-1) and four genes (p21, Erk1, Mucin 3, and
Laminin b-3) were significantly lower and higher, respectively, in
the flat-type adenoma group than those in the early invasive
carcinoma group (Table 5). On the other hand, the average
expression levels of seven genes (Erk1, Mucin 3, Laminin b-3, IGF-2,
FAK, MMP-15, and E1AF) and nine genes (Cdc42, Eph, gp130,
GST-II, Rho 8, Ras-GAP, p120, MDR1, and Egr-2) were
significantly lower and higher, respectively, in the protruded-type
adenoma group than in the early invasive carcinoma group
(Table 5).
DISCUSSION
Using a cDNA array, we analysed the gene expression profiles of
36 colorectal adenoma and 14 early invasive carcinoma tissues
to clarify characteristic changes associated with the early stage
Table 2 Average expression levels of E1AF, BMP4, IGF-2, iNOS, TIMP-1,
Smad4, and nm23 genes in tumour tissues were over five times higher than
those in the matched normal tissues
Gene name Function T average/N average
E1AF Transcription 8.11
BMP4 Growth factor 7.64
IGF-2 Growth factor 6.80
iNOS Angiogenesis 6.55
TIMP-1 Inhibitor of MMPs 6.39
Smad4 Tumour suppressor 6.03
nm23 Tumour suppressor 5.33
T average¼average expression levels in tumour tissues; N average,¼average
expression levels in matched normal tissues. The average of three experiments is
shown.
T N T N T N T N T N T N T N T N
Case 1 Case 2 Case 3 Case 4 Case 5 Case 6 Case 7 Case 8
IGF-2
GAPDH
GAPDH
GAPDH
E1AF
iNOS
Figure 1 Reverse transcriptase–polymerase chain reaction analysis of mRNA expression for IGF-2, E1AF, and iNOS in colorectal tumour tissues. T and
N, matched samples from tumour and nontumour tissue, respectively. Cases 1–4 are colorectal adenomas and cases 5–8 are colorectal carcinomas (pT1).
−3.0 1:1 3.0
Adenoma Early invasive
carcinoma Flat type Protruded type
Figure 2 A two-dimensional hierarchical clustering of 32 genes across 50 colorectal tumours. The colour in each well represents relative expression of
each gene (vertical axis) in each paired sample (horizontal axis); red, increased in tumour tissues; green, decreased in the tumour tissues. In the sample axis,
early invasive carcinomas and adenomas were separated into two different trunks. In the gene axis, 32 genes were clustered in different branches according
to their similarity; the shorter the branches, the greater the similarity. In adenomas, subclusters of flat type and protruded type were selected for further
analysis (see Figure 3).
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sof colorectal carcinogenesis. The reason why we chose early
invasive carcinoma is that it represents the early stage of colo-
rectal carcinoma. Among the 550 genes the expression profiles
of which were analysed, we chose 32 genes the average expres-
sion levels of which were at least three-fold up- or downregu-
lated in 50 tumour tissues compared with levels in 50 matched
normal tissues. Among the 13 upregulated genes, the expression
levels of E1AF, BMP-4, IGF-2, iNOS, TIMP-1, Smad4, and nm23
genes were over five-times higher than those in matched normal
tissues.
E1AF (human PEA3/ETV4) is an ets family transcriptional
factor. We recently reported that E1AF plays a key role in the
progression of colorectal carcinoma (Horiuchi et al, 2003). Thus,
our results of cDNA array analysis extend roles of E1AF in the late
stage to early stage of colorectal carcinogenesis. BMP-4 is a
member of the TGF-b superfamily of growth factors. It has been
reported that BMP-4 is overexpressed and secreted by human
colon cancer cells with mutant APC genes (Kim et al, 2002). Our
results suggest that BMP-4 overexpression plays an important role
in the early stage of colorectal carcinogenesis. iNOS has been
Table 3 Genes the expression levels of which differed significantly in the early invasive carcinoma group and the adenoma group (Mann–Whitney U-test)
Gene name Accession no. Gene function P-value
Eph M18391 Cell signalling 0.0342 CAoAD
Gp130 M57230 Cell signalling 0.0122 CAoAD
GST-II U77604 DNA repair or protection 0.0108 CAoAD
Rho 8 X95282 Cell signalling 0.0069 CAoAD
MUC-2 M74027 Glycoprotein 0.0046 CAoAD
Ras-GAP AF051311 Cell signalling 0.0035 CAoAD
P120 AF062324 Cell signalling 0.0029 CAoAD
MDR1 AF016535 Glycoprotein 0.0019 CAoAD
aN-catenin M94151 Cell adhesion 0.0014 CAoAD
Egr-2 X53700 Transcription 0.0011 CAoAD
PMS1 U13695 DNA repair or protection 0.0002 CAoAD
GAK D88435 Cell signalling 0.0001 CAoAD
IGF-2 M29645 Growth factor 0.0491 CA4AD
E1AF D12765 Transcription 0.0187 CA4AD
iNOS AB022318 Angiogenesis 0.0084 CA4AD
Rho GDIb L20688 Cell signalling 0.0002 CA4AD
GSTP1 X06547 DNA repair or protection o0.0001 CA4AD
c-jun J04111 Oncogene o0.0001 CA4AD
ECGF1 M63193 Growth factor o0.0001 CA4AD
nm23 X17620 Tumour suppressor o0.0001 CA4AD
Smad4 U44378 Tumour suppressor o0.0001 CA4AD
TIMP1 X03124 Extracellular matrix-Degrading enzymes o0.0001 CA4AD
BMP-4 D30751 Growth factor 0.7494
Cdc42 M57298 Cell cycle 0.65
Erk1 X60188 Cell signalling 0.2101
FAK L13616 Cell signalling 0.0878
Galectin-1 J04456 Extracellular matrix-degrading enzymes 0.136
HLA-DQ U77589 Human leucocyte antigen 0.8289
Laminin b-3 D37766 Cell signalling 0.7134
MMP-15 Z48482 Extracellular matrix-degrading enzymes 0.8289
Mucin 3 AF143371 Glycoprotein 0.2897
P21 U03106 CDK inhibitor 0.1734
CA¼early invasive carcinoma group; AD¼adenoma group.
−3.0 1:1 3.0
Flat type Protruded type
Figure 3 A two-dimensional hierarchical clustering of 32 genes across 36 colorectal adenomas. The colour in each well represents relative expression of
each gene (vertical axis) in each paired sample (horizontal axis); red, increased in adenoma tissues; green, decreased in adenoma tissues. In the sample axis,
flat- and protruded-type adenomas were separated into two different trunks.
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sreported to play a crucial role in cancer development by promoting
angiogenesis (Jenkins et al, 1995). Our results are consistent with
those of previous studies showing an important role of iNOS in the
early stage of colorectal carcinogenesis (Xu et al, 2003). Interest-
ingly, nitric oxide (NO), generated by iNOS, reportedly augments
the synergistic interaction between E1AF and its transcription
coactivator CBP/p300, resulting in the facilitation of induction of
tumour-related genes, such as COX-2 (Liu et al, 2004).
Several lines of evidence suggest that IGF-2 plays an important
role in the progression of colorectal tumours (Lambert et al, 1990).
Moreover, expression of IGF-2 protein has been reported to be
associated with advanced tumour stage and poor survival
(Kawamoto et al, 1998; Peters et al, 2003). It has also been
suggested that IGF-2 plays a role in the development of liver
metastasis from colorectal cancer (Kawamoto et al, 1999). Thus,
our results extend roles of IGF-2 in the late stage to early stage of
colorectal carcinogenesis.
Among the four known tissue inhibitors of metalloproteinases
(TIMPs), TIMP-1 has functions apart from its protease inhibitory
action. Several investigators have reported that TIMP-1 has
growth-promoting properties and might also stimulate tumour
growth by inhibiting apoptosis (Holten-Andersen et al, 2002).
Overexpression of TIMP-1 has been reported in colorectal cancer
tissues (Murashige et al, 1996). Holten-Andersen et al (2005)
recently reported that TIMP-1 mRNA was detected in all of 24
cases of colorectal cancer tissues by in situ hybridisation, but it
was detected in only two of seven adenoma tissues. In the current
study, we also found that the average expression levels of TIMP-1
were significantly higher in the early invasive carcinoma group
than in the adenoma group. Besides, levels of TIMP-1 in blood
were significantly elevated in colorectal cancer patients compared
to healthy donors, and high plasma TIMP-1 levels were associated
with short survival of colorectal cancer patients (Holten-Andersen
et al, 2005). Therefore, TIMP-1 appears to be a novel marker for
detection of early colorectal cancer and for prognostic stratifica-
tion of colorectal cancer patients.
Smad4 is an intracellular transmitter of TGF-b signals and its
tumour suppressor function is presumed to reside in its capacity to
mediate TGF-b-induced growth inhibition. However, there is
accumulating evidence that this hypothesis may be too simple
(Muller et al, 2002). Although functional inactivation of Smad4 in
colorectal cancer frequently occurs at late stages when tumours
acquire invasive and metastatic capabilities, the roles of TGF-b
signals in carcinogenesis are complex and also comprise tumour-
promoting functions in colorectal carcinogenesis (Muller et al,
2002; Reinacher-Schick et al, 2004). Nevertheless, the reason for
the overexpression of Smad4 in early colorectal tumour tissues
remains unknown. It may be induced to inhibit tumour growth by
some compensatory mechanisms. Further analysis is needed to
clarify this issue.
The nm23 gene was first identified as a gene the expression level
of which was reduced in highly metastatic rodent tumours relative
to poorly metastatic tumour cells (Steeg et al, 1988). The
transfection of nm23 cDNA into various cancer cell lines resulted
in suppression of the metastatic potential of motility, invasion, or
colonisation (Suzuki et al, 2004). However, Bertucci et al (2004)
recently reported over- and downexpression of nm23 in colorectal
cancer tissues and in those with poor prognosis, respectively. The
reason why nm23 gene was highly expressed in tumour tissues in
the current study may be due to the fact that all tumour samples
Table 4 Genes the expression levels of which differed significantly in the flat-type adenoma group and the protruded-type adenoma group (Mann–
Whitney U-test)
Gene name Accession no. Gene function P-value
PMS1 U13695 DNA repair or protection 0.0136 PoF
nm23 X17620 Tumour suppressor 0.0004 PoF
p21 U03106 CDK inhibitor 0.001 PoF
FAK L13616 Cell signalling 0.0017 PoF
Smad4 U44378 Tumour suppressor 0.0429 PoF
c-jun J04111 Oncogene o0.0001 PoF
ECGF1 M63193 Growth factor o0.0001 PoF
Erk1 X60188 Cell signalling o0.0001 PoF
GAK D88435 Cell signalling o0.0001 PoF
GSTP1 X06547 DNA repair or protection o0.0001 PoF
IGF-2 M29645 Growth factor o0.0001 PoF
Laminin b-3 D37766 Cell signalling o0.0001 PoF
MMP-15 Z48482 Extracellular matrix-degrading enzymes o0.0001 PoF
Mucin 3 AF143371 Glycoprotein o0.0001 PoF
Rho GDIb L20688 Cell signalling o0.0001 PoF
TIMP1 X03124 Extracellular matrix-degrading enzymes o0.0001 PoF
HLA-DQ U77589 Human leucocyte antigen 0.0003 P4F
Cdc42 M57298 Cell cycle o0.0001 P4F
Egr-2 X53700 Transcription o0.0001 P4F
Eph M18391 Cell signalling o0.0001 P4F
Galectin-1 J04456 Extracellular matrix-degrading enzymes o0.0001 P4F
Gp130 M57230 Cell signalling o0.0001 P4F
GST-II U77604 DNA repair or protection o0.0001 P4F
MDR1 AF016535 Glycoprotein o0.0001 P4F
p120 AF062324 Cell signalling o0.0001 P4F
Ras-GAP AF051311 Cell signalling o0.0001 P4F
Rho 8 X95282 Cell signalling o0.0001 P4F
E1AF D12765 Transcription 0.1488
iNOS AB022318 Angiogenesis 0.1639
BMP-4 D30751 Growth factor 0.1966
MUC-2 M74027 Glycoprotein 0.4107
aN-catenin M94151 Cell adhesion 0.5478
F¼flat-type adenoma group; P¼protruded-type adenoma group.
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sconsisted of early colorectal tumours without metastasis. Further
analysis is needed to clarify this issue.
We identified 22 genes the expression levels of which differed
significantly in colorectal adenomas and early invasive carci-
nomas. Colorectal adenomas and early invasive carcinomas were
divided into two major clusters by clustering analysis. This result
is consistent with that of a recent study showing that nine
colorectal adenomas were separated from 11 differentiated colo-
rectal carcinomas by using oligonucleotide arrays (Lin et al, 2002).
The expression profiles obtained by our cDNA array demonstrated
that colorectal adenomas and early invasive carcinomas have
specific expression profiles. Among the seven upregulated genes
the expression levels of which were over five times higher than
those in the matched normal tissues, the expression levels of IGF-2,
E1AF, iNOS, nm23, Smad4, and TIMP-1 genes were significantly
higher in the early invasive carcinoma group than in the adenoma
group. These results suggest that these genes play an important
role in the progression from adenoma to carcinoma.
On the other hand, GAK was the most downregulated gene in
the early invasive carcinoma group relative to the adenoma group.
GAK is a serine/threonine kinase that shows high homology
outside its kinase domain with auxilin. Like auxilin, GAK has been
shown to be a cofactor for uncoating clathrin vesicles in vitro.
Zhang et al (2004) reported that downregulation of GAK by small
hairpin RNA increased the levels of epidermal growth factor (EGF)
receptor expression and tyrosine kinase activity, resulting in a
large increase in the levels of activated extracellular signal-
regulated kinase 5 and Akt. Moreover, downregulation of GAK
has been reported to result in outgrowth of monkey kidney CV1P
cells in soft agar, raising the possibility that loss of GAK function
may promote tumorigenesis. Thus, our results suggest that
downregulation of GAK plays an important role in the progression
from colorectal adenoma to carcinoma.
The adenoma–carcinoma sequence (ACS) is widely accepted as
a pathogenesis of colorectal carcinoma. A multistep genetic model
for colorectal carcinogenesis based on the ACS has been proposed
(Vogelstein et al, 1988). In the ACS sequence, mutations in the
K-ras gene and various tumour suppressor genes, such as APC and
p53, are known to accumulate during the progression from normal
to malignant tissue. Although coexistence of all three mutations
has been reported to be a rare occurrence (Smith et al, 2002), the
majority of sporadic colorectal carcinomas are still thought to
develop and progress through this pathway. It has been thought
that de novo cancers develop from normal colonic mucosa directly.
However, critical genetic abnormality is not known. Most
protruded-type colorectal cancers have adenomatous elements in
the periphery when found at an early stage, suggesting that these
cancers have arisen from pre-existing adenomas. On the other
hand, adenomatous components are not detectable microscopi-
cally in some flat-type cancers, suggesting that flat-type cancers
correspond to de novo cancer (Yashiro et al, 2001). The reason
why we could not detect any changes in the expression of APC,
p53, and K-ras genes may be due to the fact that mutations of these
genes do not necessarily result in alterations of mRNA expression
levels.
In the current study, flat- and protruded-type adenomas were
divided into two major clusters by clustering analysis. We
identified 27 genes the expression levels of which differed
significantly in flat- and protruded-type adenomas. The expression
levels of 16 genes (PMS1, nm23, p21, FAK, Smad4, c-jun, ECGF-1,
Table 5 Genes the expression levels of which differed significantly in the early invasive carcinoma group and the protruded-type (28 genes) or flat-type
(18 genes) adenoma group (Mann-Whitney U-test)
Gene name Accession no. P-value P-value
BMP-4 D30751 0.6128 0.2968
Cdc42 M57298 0.001 CAoAD (P) 0.0122 CA4AD (F)
c-jun J04111 o0.0001 CA4AD (P) 0.0135 CA4AD (F)
E1AF D12765 0.0086 CA4AD (P) 0.13
ECGF1 M63193 o0.0001 CA4AD (P) 0.0002 CA4AD (F)
Egr-2 X53700 o0.0001 CAoAD (P) 0.3423
Eph M18391 0.0005 CAoAD (P) 0.7903
Erk1 X60188 o0.0001 CA4AD (P) 0.0276 CAoAD (F)
FAK L13616 0.0304 CA4AD (P) 0.4033
GAK D88435 0.0227 CAoAD (P) o0.0001 CAoAD (F)
Galectin-1 J04456 0.704 0.0027 CA4AD (F)
Gp130 M57230 o0.0001 CAoAD (P) 0.9093
GST-II U77604 o0.0001 CAoAD (P) 0.8197
GSTP1 X06547 o0.0001 CA4AD (P) 0.0006 CA4AD (F)
HLA-DQ U77589 0.1489 0.0682
IGF-2 M29645 0.0034 CA4AD (P) 0.5937
iNOS AB022318 0.0402 CA4AD (P) 0.0098 CA4AD (F)
Laminin b-3 D37766 0.0016 CA4AD (P) 0.0001 CAoAD (F)
MDR1 AF016535 o0.0001 CAoAD (P) 0.4941
MMP-15 Z48482 0.025 CA4AD (P) 0.0627
MUC-2 M74027 0.0044 CAoAD (P) 0.0334 CAoAD (F)
Mucin 3 AF143371 o0.0001 CA4AD (P) 0.0227 CAoAD (F)
nm23 X17620 o0.0001 CA4AD (P) 0.0001 CA4AD (F)
p120 AF062324 o0.0001 CAoAD (P) 0.4941
p21 U03106 0.7324 0.0402 CAoAD (F)
PMS1 U13695 0.0044 CAoAD (P) 0.0002 CAoAD (F)
Ras-GAP AF051311 o0.0001 CAoAD (P) 0.7324
Rho 8 X95282 o0.0001 CAoAD (P) 0.8494
Rho GDIb L20688 o0.0001 CA4AD (P) 0.0304 CA4AD (F)
Smad4 U44378 o0.0001 CA4AD (P) o0.0001 CA4AD (F)
TIMP1 X03124 o0.0001 CA4AD (P) 0.0024 CA4AD (F)
aN-catenin M94151 0.0014 CAoAD (P) 0.0151 CAoAD (F)
CA¼early invasive carcinoma group; AD (P)¼protruded-type adenoma group; AD (F)¼flat-type adenoma group.
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GDIb, and TIMP-1) were significantly higher in the flat-type group
than in the protruded-type group. On the other hand, the
expression levels of 11 genes (HLA-DQ, Cdc42, Egr-2, Eph,
Galectin-1, gp130, GST-II, MDR1, p120, Ras-GAP, and Rho 8)
were significantly lower in the flat-type group than in the
protruded-type group.
Among the 18 genes the expression levels of which were
significantly different in the early invasive carcinoma group and
the flat-type adenoma group, the expression levels of eight genes
(p21, MUC-2, Erk1, Mucin 3, aN-catenin, PMS1, Lamin b3, and
GAK) and 10 genes (Rho GDIb, c-jun, Cdc42, iNOS, Galectin-1,
TIMP-1, GSTP1, ECGF1, nm23, and Smad4) were significantly
higher and lower, respectively, in the flat-type adenoma group
than in the early invasive cancer group. On the other hand, among
the 28 genes the expression levels of which were significantly
different in the early invasive carcinoma group and the protruded-
type adenoma group, the expression levels of 13 genes (GAK,
MUC-2, PMS1, aN-catenin, Cdc42, Eph, gp130, GST-II, Rho 8, Ras-
GAP, p120, MDR1, and Egr-2) and 15 genes (iNOS, FAK, MMP-15,
E1AF, IGF-2, Laminin b3, Smad4, TIMP1, nm23, Rho GDIb,
GSTP1, c-jun, ECGF1, Erk1, and Mucin 3) were significantly higher
and lower, respectively, in the protruded-type adenoma group than
in the early invasive cancer group. These results suggest that flat-
and protruded-type adenomas have specific expression profiles
and that genes that play a crucial role in the progression from each
type of adenoma to carcinoma are different.
In conclusion, the expression profiles obtained by the cDNA
array clearly indicate that colorectal adenomas and early invasive
carcinomas have specific expression profiles. Likewise, the gene
expression profiles of flat- and protruded-type adenomas are
different. These results indicate that molecular classification of
early colorectal tumours by a cDNA array is feasible.
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